Watch out, CBD – these two lesser-known cannabis compounds could be the next hottest trend…
In the cannabis industry, we all know 2019 was the “Year of CBD.”
From gas stations to Sephora, it seemed like everywhere you went, you could buy some type of CBD product.
It makes sense.
Researchers are still studying all the powers of cannabis-based medicine, but CBD has shown that it can relieve pain, reduce anxiety and depression, lower high blood pressure, and help with substance abuse treatment.
The word is spreading about all of the potential benefits, and that’s why someone who has never used CBD before is willing to pay $39.99 at CVS to buy hemp balm on a whim.
In 2018, the U.S. CBD industry was worth roughly $620 million, and as I mentioned, things have really ramped up.
I conservatively projected sales would reach $2 billion, but I also said I wouldn’t be surprised if sales totaled $3 billion this year. The CBD market will continue to experience explosive growth, with sales potentially climbing to $23.7 billion by 2023.
However, CBD is not the only powerful cannabis compound out there.
The Rise of THCV and CBN
Tetrahydrocannabivarin, or THCV for short, appears in small quantities in the marijuana plant.
It can produce a psychoactive effect in high dosages like THC but, unlike THC, it can work as an appetite suppressant. In fact, some brands are now focusing on selling products high in THCV because customers are saying it’s helping with weight loss.
The idea that there is a specific cannabis compound that can suppress one’s appetite rather than increase it, as cannabis is better known for, is astounding.
And that’s not all. A 2013 study found that THCV could be used as a medicine or paired with other medicines to help treat Type 2 diabetes. Another study found that THCV could alleviate symptoms for those with Parkinson’s and even delay disease progression.
There’s a lot of promise behind this compound, but there is also still a lot to learn.
In fact, in 2018, Cronos Group Inc. (Nasdaq: CRON) made a $122 million deal with Ginkgo Bioworks, a Boston-based bioengineering company.
Through the partnership, the bioengineering firm will create rare cannabinoids in large quantities, and one of those compounds is THCV.
Expect to hear a lot more about THCV in 2020.
Evidence of cannabis health benefits proceeds to grow. Researchers continue to uncover the healing powers of cannabis, which is good news for consumers, companies, and investors like you. These new developments have big pharma shaking in their boots.
CBN as a Sleep Aid
A lot of people who consume CBD do so because it helps them relax but still keeps them alert.
CBN, on the other hand, has been found to offer a sedative effect.
A 2016 survey from Consumer Reports found that 27% of adults in the United States had trouble falling asleep.
And another study published earlier this month found that over-the-counter sleep aid sales have plummeted by as much as 236% in Colorado since recreational cannabis became legal – suggesting that consumers actually prefer cannabis as a sleep aid when given the option.
It would only make sense, then, that CBN could be turned to as a sleep aid.
There need to be more studies done, but the compound still has a lot of promise.
It could give people the chance to stop using heavy drugs or self-medicating to fall asleep.
It has also been found to provide symptom relief for arthritis, seizures, and Crohn’s disease.
These are two of the compounds you’ll hear about the most in 2020 (outside of CBD and THC), but this is just the start.
With more research, the true powers of the cannabis plant will be unlocked, and we will know more about the health benefits of cannabis than ever before.
The cannabis industry as a whole is still in its infancy stage, which gives you a ground-floor opportunity that you may never see again.
That’s why my team at the National Institute for Cannabis Investors released this free guide on the “Best Pot Stocks to Buy in 2020.”
In it, you’ll find out our picks for the best short-term profit opportunities and the best long-term profit opportunities.
P.S. This tiny startup is about to take the world by storm with one very special product. To be clear, this product doesn’t contain THC. It’s not going to get you high. All it’s going to deliver is a mild calming effect. And what’s most impressive is the product could help investors see an increase of 35x in the next 24 months alone…
12 responses to “2020 Cannabis Trends: The Rise of THCV and CBN”
December 26 2019